Brighton Jones’s Coherus Oncology CHRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-12,803
Closed -$17.9K – 1413
2026
Q2
$17.9K Buy
+12,803
New +$20.9K ﹤0.01% 1405

Other funds holding CHRS

Brighton Jones's CHRS Position: Q3 2026 in Review

Brighton Jones sold out of Coherus Oncology (CHRS) in Q3 2026, closing a stake of 12,803 shares — an estimated $17.9K sold.

Brighton Jones first reported a position in CHRS in Q2 2026 and held it in 1 quarter. The position peaked at $17.9K in Q2 2026. 134 funds tracked by Wall St. Rank hold CHRS as of Q3 2026.

  • Brighton Jones reported no remaining Coherus Oncology position as of Q3 2026 after selling out during the quarter.
  • Brighton Jones sold 12,803 Coherus Oncology shares in Q3 2026, an estimated $17.9K.
  • Brighton Jones first reported a position in Coherus Oncology in Q2 2026 and held it in 1 quarter.
  • Brighton Jones's Coherus Oncology position peaked at $17.9K in Q2 2026.
  • 134 funds tracked by Wall St. Rank held Coherus Oncology as of Q3 2026.

Based on Brighton Jones's 13F filing for Q3 2026, filed 3 Nov 2026.